Journal of Diabetes Research

Journal of Diabetes Research / 2016 / Article

Erratum | Open Access

Volume 2016 |Article ID 1213892 | 2 pages | https://doi.org/10.1155/2016/1213892

Erratum to “NADPH Oxidase-Induced NALP3 Inflammasome Activation Is Driven by Thioredoxin-Interacting Protein Which Contributes to Podocyte Injury in Hyperglycemia”

Received12 Dec 2015
Accepted05 Jan 2016
Published13 Jan 2016

In Figure 6 in the paper titled “NADPH Oxidase-Induced NALP3 Inflammasome Activation Is Driven by Thioredoxin-Interacting Protein Which Contributes to Podocyte Injury in Hyperglycemia” [1], Figures 6(a) and 6(c) are completely the same pictures. This correction does not have any influence on the results and discussions of the study, which are correctly described in the text. In the published version of Gao et al., 2015, Figure 6(a) should be the representative Western blot graph of the expression of gp91phox in HG-exposed podocytes without or with TXNIP shRNA transfection. Below is the correct version of Figure 6.

References

  1. P. Gao, F.-F. He, H. Tang et al., “NADPH oxidase-induced NALP3 inflammasome activation is driven by thioredoxin-interacting protein which contributes to podocyte injury in hyperglycemia,” Journal of Diabetes Research, vol. 2015, Article ID 504761, 12 pages, 2015. View at: Publisher Site | Google Scholar

Copyright © 2016 Pan Gao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

643 Views | 338 Downloads | 2 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.